ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis. It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and medical devices with anti-microbial and anti-fouling coating. The company was formerly known as Trenchant Life Sciences Investment Corp. ASEP Medical Holdings Inc. was incorporated in 2020 and is headquartered in Victoria, Canada.
| 0.116 | |
| 0.116 | |
| - | |
| 0.116 | |
| 0.116 | |
| 0.05-0.25 | |
| 8 851 K | |
| 76 306 K | |
| 169 K | |
| -0.0108 | |
| -2.36 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
